Article

Results reported: Ocular implant safe for AMD in early tests

Rockville, MD-Ocular implants of EntreMed's 2-methoxyestradiol (Panzem) showed no toxicity and effectively inhibited the growth of new blood vessels in preclinical models of age-related macular degeneration (AMD), the company said.

Newsletter

Don’t miss out—get Ophthalmology Times updates on the latest clinical advancements and expert interviews, straight to your inbox.

Related Videos
(Image credit: Ophthalmology Times) CCOI sets the stage for global ophthalmic innovation at Stanford Summit on July 23
(Image credit: Ophthalmology Times) Accelerating eye health innovation through CCOI – Stanford Summit
(Image credit: Ophthalmology Times) 50 years of ophthalmology: What changed the game (Part 2)
© 2025 MJH Life Sciences

All rights reserved.